1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Rheumatism in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Egido, J; Herrero-Beaumont, G | 1 |
| Arnoux, B; Benveniste, J; Dulioust, A; Hilliquin, P; Menkes, CJ | 1 |
| Arnoux, B; Benveniste, J; Hilliquin, P; Laoussadi, S; Menkes, CJ | 1 |
3 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Rheumatism
| Article | Year |
|---|---|
PAF, a potent proinflammatory mediator, looking for its role in the pathogenesis of joint damage.
Topics: Cytokines; Endothelium, Vascular; Extracellular Matrix Proteins; Humans; Joint Diseases; Neutrophils; Platelet Activating Factor; Rheumatic Diseases; Signal Transduction; Synovial Membrane | 1997 |
Paf-acether acetylhydrolase activity is increased in patients with rheumatic diseases.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Humans; Osmolar Concentration; Phospholipases A; Platelet Activating Factor; Rheumatic Diseases; Synovial Fluid | 1992 |
Presence of paf-acether in rheumatic diseases.
Topics: Arthritis, Rheumatoid; Chondrocalcinosis; Humans; Lipoproteins; Platelet Activating Factor; Rheumatic Diseases; Synovial Fluid | 1992 |